D-Wave Systems adds two new partnerships as part of its application ecosystem. According to a media release, DNA-SEQ and 1QBit are developing software applications that take advantage of D-Wave's unique quantum computing capabilities.
"Quantum computing will reach its full potential through collaborative partnerships with pioneering organizations like DNA- SEQ and 1QBit, who are working to solve incredibly complex problems," said
To support the building of an application ecosystem, D-Wave Systems provides access to its quantum computers and the expertise necessary to map specific problems onto its quantum hardware. DNA- SEQ and 1QBit are working closely with D-Wave to develop machine learning and optimization techniques to address critical real-world applications.
DNA-SEQ aims to enable more precisely targeted drug therapies for cancer patients by using 3D precision crystallography, and a patient's full genomic data, to identify early drug resistance and to match their specific mutations to more effective therapies. Existing technology can only analyze small amounts of genomic data, limiting the ability to match a patient's specific mutation to the optimal cancer drug. Ongoing collaborations with the Children's Hospital Los Angeles,
"Exploring cancer genomics using 3D crystallography and full genomic data enables extraordinary pattern matching of mutations to available drugs, and it is only possible with D-Wave's unique computational machine learning capabilities and our crystal structures libraries," said Dr.
More information and complete details:
((Comments on this story may be sent to firstname.lastname@example.org))
D-Wave Systems adds two new partnerships as part of its application ecosystem.
According to a media release, DNA-SEQ and 1QBit are developing software applications that take advantage of D-Wave's unique quantum computing capabilities.